PacificHealth Laboratories, Inc.
PHLI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $7 | $7 | $8 | $7 |
| % Growth | -4% | -9.9% | 10.5% | – |
| Cost of Goods Sold | $4 | $4 | $5 | $4 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 43.2% | 43.9% | 40.3% | 41.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $3 | $3 | $4 |
| SG&A Expenses | $3 | $4 | $5 | $4 |
| Sales & Mktg Exp. | $1 | $1 | $2 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $4 | $5 | $5 |
| Operating Income | -$0 | -$1 | -$2 | -$2 |
| % Margin | -6.9% | -10.6% | -24.3% | -28.2% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$1 | -$2 | -$2 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$0 | -$1 | -$2 | -$2 |
| % Margin | -7% | -10.6% | -21% | -27.6% |
| EPS | -0.025 | -0.047 | -0.11 | -0.15 |
| % Growth | 47.2% | 57.1% | 26.7% | – |
| EPS Diluted | -0.025 | -0.047 | -0.11 | -0.15 |
| Weighted Avg Shares Out | 20 | 16 | 15 | 14 |
| Weighted Avg Shares Out Dil | 20 | 16 | 15 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$2 | -$2 |
| % Margin | -6.2% | -9.1% | -21.7% | -25.3% |